Canada should use COVID-19 resources to tackle the “silent pandemic” of antimicrobial resistance (AMR), says a group of health experts that includes Global Nexus' Gerry Wright.
A team of researchers at McMaster University is working on an inhaled COVID-19 vaccine that offers better protection and is less costly to produce, store and ship.
We need more than drug discovery and development — we need social scientists, policy makers, communicators, economists and more — to solve the problem of antimicrobial resistance, experts at the AMR symposium said.
McMaster logo
McMaster logo
